Section 3: Efficacy of Anisoylated Plasminogen Streptokinase Activator Complex: Evidence of Myocardial Function and Mortality Benefit
18 October 2012
Pages: 191 - 197
Section 3: Efficacy of Anisoylated Plasminogen Streptokinase Activator Complex: Evidence of Myocardial Function and Mortality Benefit
18 October 2012
Pages: 198 - 208
Section 3: Efficacy of Anisoylated Plasminogen Streptokinase Activator Complex: Evidence of Myocardial Function and Mortality Benefit
18 October 2012
Pages: 209 - 215
Section 3: Efficacy of Anisoylated Plasminogen Streptokinase Activator Complex: Evidence of Myocardial Function and Mortality Benefit
18 October 2012
Pages: 216 - 220
Section 3: Efficacy of Anisoylated Plasminogen Streptokinase Activator Complex: Evidence of Myocardial Function and Mortality Benefit
18 October 2012
Pages: 231 - 234
Section 3: Efficacy of Anisoylated Plasminogen Streptokinase Activator Complex: Evidence of Myocardial Function and Mortality Benefit
18 October 2012
Pages: 235 - 236